AMPK promotes skeletal muscle autophagy through activation of forkhead FoxO3a and interaction with Ulk1

In skeletal muscle, protein levels are determined by relative rates of protein synthesis and breakdown. The balance between synthesis and degradation of intracellular components determines the overall muscle fiber size. AMP‐activated protein kinase (AMPK), a sensor of cellular energy status, was recently shown to increase myofibrillar protein degradation through the expression of MAFbx and MuRF1. In the present study, the effect of AMPK activation by AICAR on autophagy was investigated in muscle cells. Our results show that FoxO3a transcription factor activation by AMPK induces the expression of the autophagy‐related proteins LC3B‐II, Gabarapl1, and Beclin1 in primary mouse skeletal muscle myotubes and in the Tibialis anterior (TA) muscle. Time course studies reveal that AMPK activation by AICAR leads to a transient nuclear relocalization of FoxO3a followed by an increase of its cytosolic level. Moreover, AMPK activation leads to the inhibition of mTORC1 and its subsequent dissociation of Ulk1, Atg13, and FIP200 complex. Interestingly, we identify Ulk1 as a new interacting partner of AMPK in muscle cells and we show that Ulk1 is associated with AMPK under normal conditions and dissociates from AMPK during autophagy process. Moreover, we find that AMPK phosphorylates FoxO3a and Ulk1. In conclusion, our data show that AMPK activation stimulates autophagy in skeletal muscle cells through its effects on the transcriptional function of FoxO3a and takes part in the initiation of autophagosome formation by interacting with Ulk1. Here, we present new evidences that AMPK plays a crucial role in the fine tuning of protein expression programs that control skeletal muscle mass. J. Cell. Biochem. 113: 695–710, 2012. © 2011 Wiley Periodicals, Inc.

[1]  Sebastian Alers,et al.  Ulk1-mediated phosphorylation of AMPK constitutes a negative regulatory feedback loop , 2011, Autophagy.

[2]  Xiaodong Wang,et al.  Nutrient starvation elicits an acute autophagic response mediated by Ulk1 dephosphorylation and its subsequent dissociation from AMPK , 2011, Proceedings of the National Academy of Sciences.

[3]  B. Viollet,et al.  AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1 , 2011, Nature Cell Biology.

[4]  B. Viollet,et al.  Phosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to Mitophagy , 2011, Science.

[5]  Hong-Gang Wang,et al.  The Association of AMPK with ULK1 Regulates Autophagy , 2010, PloS one.

[6]  Wei-Guo Zhu,et al.  Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity , 2010, Nature Cell Biology.

[7]  S. Gygi,et al.  Network organization of the human autophagy system , 2010, Nature.

[8]  Luca Scorrano,et al.  Mitochondrial fission and remodelling contributes to muscle atrophy , 2010, The EMBO journal.

[9]  A. Poupon,et al.  The Translation Regulatory Subunit eIF3f Controls the Kinase-Dependent mTOR Signaling Required for Muscle Differentiation and Hypertrophy in Mouse , 2010, PloS one.

[10]  J. Cleveland,et al.  Mapping the phosphorylation sites of Ulk1. , 2009, Journal of proteome research.

[11]  T. Natsume,et al.  Atg101, a novel mammalian autophagy protein interacting with Atg13 , 2009, Autophagy.

[12]  J. Tong,et al.  AMP‐activated protein kinase enhances the expression of muscle‐specific ubiquitin ligases despite its activation of IGF‐1/Akt signaling in C2C12 myotubes , 2009, Journal of cellular biochemistry.

[13]  D. Williamson,et al.  AMPK inhibits myoblast differentiation through a PGC-1alpha-dependent mechanism. , 2009, American journal of physiology. Endocrinology and metabolism.

[14]  She Chen,et al.  ULK1·ATG13·FIP200 Complex Mediates mTOR Signaling and Is Essential for Autophagy* , 2009, Journal of Biological Chemistry.

[15]  J. Blenis,et al.  Molecular mechanisms of mTOR-mediated translational control , 2009, Nature Reviews Molecular Cell Biology.

[16]  C. Jung,et al.  ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. , 2009, Molecular biology of the cell.

[17]  J. Guan,et al.  Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. , 2009, Molecular biology of the cell.

[18]  D. Sabatini,et al.  An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1* , 2009, Journal of Biological Chemistry.

[19]  Taichi Hara,et al.  Role of ULK-FIP200 complex in mammalian autophagy: FIP200, a counterpart of yeast Atg17? , 2009, Autophagy.

[20]  K. Otsu,et al.  Crosstalk Between Autophagy and Apoptosis in Heart Disease , 2008, Circulation research.

[21]  D. Klionsky,et al.  Atg8 controls phagophore expansion during autophagosome formation. , 2008, Molecular biology of the cell.

[22]  K. Nakashima,et al.  Effects of orally administered glycine on myofibrillar proteolysis and expression of proteolytic-related genes of skeletal muscle in chicks , 2008, Amino Acids.

[23]  J. Guan,et al.  FIP200, a ULK-interacting protein, is required for autophagosome formation in mammalian cells , 2008, The Journal of cell biology.

[24]  B. Viollet,et al.  Role of adenosine 5'-monophosphate-activated protein kinase subunits in skeletal muscle mammalian target of rapamycin signaling. , 2008, Molecular endocrinology.

[25]  A. Brunet,et al.  The FoxO code , 2008, Oncogene.

[26]  S. Gordon,et al.  AMPK activation attenuates S6K1, 4E-BP1, and eEF2 signaling responses to high-frequency electrically stimulated skeletal muscle contractions. , 2008, Journal of applied physiology.

[27]  A. Goldberg,et al.  FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. , 2007, Cell metabolism.

[28]  A. Goldberg,et al.  FoxO3 controls autophagy in skeletal muscle in vivo. , 2007, Cell metabolism.

[29]  S. Gygi,et al.  The Energy Sensor AMP-activated Protein Kinase Directly Regulates the Mammalian FOXO3 Transcription Factor* , 2007, Journal of Biological Chemistry.

[30]  D. Hardie,et al.  AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy , 2007, Nature Reviews Molecular Cell Biology.

[31]  K. Nakashima,et al.  AMPK Activation Stimulates Myofibrillar Protein Degradation and Expression of Atrophy-Related Ubiquitin Ligases by Increasing FOXO Transcription Factors in C2C12 Myotubes , 2007, Bioscience, biotechnology, and biochemistry.

[32]  T. P. Neufeld,et al.  Direct Induction of Autophagy by Atg1 Inhibits Cell Growth and Induces Apoptotic Cell Death , 2007, Current Biology.

[33]  M. Hirata,et al.  Lysosomal Turnover of GABARAP-Phospholipid Conjugate is Activated During Differentiation of C2C12 Cells to Myotubes without Inactivation of the mTor Kinase-Signaling Pathway , 2006, Autophagy.

[34]  M. Hall,et al.  TOR Signaling in Growth and Metabolism , 2006, Cell.

[35]  Z. Qin,et al.  Molecular mechanism and regulation of autophagy , 2005, Acta Pharmacologica Sinica.

[36]  P. Codogno,et al.  Autophagy and signaling: their role in cell survival and cell death , 2005, Cell Death and Differentiation.

[37]  Mark M. Kockx,et al.  Amino Acid Deprivation Induces Both Apoptosis and Autophagy in Murine C2C12 Muscle Cells , 2005, Biotechnology Letters.

[38]  P. Codogno,et al.  Regulation and role of autophagy in mammalian cells. , 2004, The international journal of biochemistry & cell biology.

[39]  S. Kandarian,et al.  The molecular basis of skeletal muscle atrophy. , 2004, American journal of physiology. Cell physiology.

[40]  Hiroyuki Aburatani,et al.  Skeletal Muscle FOXO1 (FKHR) Transgenic Mice Have Less Skeletal Muscle Mass, Down-regulated Type I (Slow Twitch/Red Muscle) Fiber Genes, and Impaired Glycemic Control*[boxs] , 2004, Journal of Biological Chemistry.

[41]  Marco Sandri,et al.  Foxo Transcription Factors Induce the Atrophy-Related Ubiquitin Ligase Atrogin-1 and Cause Skeletal Muscle Atrophy , 2004, Cell.

[42]  A. Goldberg,et al.  Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[43]  M. Matsui,et al.  In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. , 2003, Molecular biology of the cell.

[44]  K. Inoki,et al.  TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival , 2003, Cell.

[45]  C. Proud,et al.  Regulation of targets of mTOR (mammalian target of rapamycin) signalling by intracellular amino acid availability. , 2003, The Biochemical journal.

[46]  K. Esser,et al.  Translational control: implications for skeletal muscle hypertrophy. , 2002, Clinical orthopaedics and related research.

[47]  A. Goldberg,et al.  Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[48]  G. Yancopoulos,et al.  Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo , 2001, Nature Cell Biology.

[49]  C. Rommel,et al.  Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways , 2001, Nature Cell Biology.

[50]  D J Glass,et al.  Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy , 2001, Science.

[51]  R. Fitts,et al.  Functional and structural adaptations of skeletal muscle to microgravity. , 2001, The Journal of experimental biology.

[52]  A. Goldberg,et al.  What do we really know about the ubiquitin-proteasome pathway in muscle atrophy? , 2001, Current opinion in clinical nutrition and metabolic care.

[53]  Takeshi Noda,et al.  LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing , 2000, The EMBO journal.

[54]  B. Hansen,et al.  Isoform‐specific and exercise intensity‐dependent activation of 5′‐AMP‐activated protein kinase in human skeletal muscle , 2000, The Journal of physiology.

[55]  J. Connell,et al.  5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytes. , 2000, Diabetes.

[56]  D. Carling,et al.  Characterization of the Role of AMP-Activated Protein Kinase in the Regulation of Glucose-Activated Gene Expression Using Constitutively Active and Dominant Negative Forms of the Kinase , 2000, Molecular and Cellular Biology.

[57]  W. Derave,et al.  Dissociation of AMP-activated protein kinase activation and glucose transport in contracting slow-twitch muscle. , 2000, Diabetes.

[58]  M. Greenberg,et al.  Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor , 1999, Cell.

[59]  Michael D. George,et al.  A protein conjugation system essential for autophagy , 1998, Nature.

[60]  W. Cavenee,et al.  Cloning and characterization of three human forkhead genes that comprise an FKHR-like gene subfamily. , 1998, Genomics.

[61]  B. Kemp,et al.  Contraction-induced Changes in Acetyl-CoA Carboxylase and 5′-AMP-activated Kinase in Skeletal Muscle* , 1997, The Journal of Biological Chemistry.

[62]  A. Goldberg,et al.  Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. , 1996, The New England journal of medicine.

[63]  A. Edelman,et al.  Similar substrate recognition motifs for mammalian AMP‐activated protein kinase, higher plant HMG‐CoA reductase kinase‐A, yeast SNF1, and mammalian calmodulin‐dependent protein kinase I , 1995, FEBS letters.

[64]  K. Ball,et al.  Specificity determinants for the AMP‐activated protein kinase and its plant homologue analysed using synthetic peptides , 1993, FEBS letters.

[65]  M. Castro,et al.  Influence of complete spinal cord injury on skeletal muscle within 6 mo of injury. , 1999, Journal of applied physiology.